相关实验视频
Updated: Jul 7, 2026

03:53
Extracellular Vesicle Tissue Factor Activity Assay
Published on: December 29, 2023
热血素诱导的血小板激活被高分子和低分子重量的肝素抑制
E De Candia1, R De Cristofaro, R Landolfi
1Istituto di Semeiotica Medica, Università Cattolica del Sacro Cuore, Rome, Italy.
Circulation
|June 29, 1999
概括
氨酸通过阻断氨酸-糖蛋白Ib相互作用来抑制氨酸诱导的血小板激活. 较高分子量的肝素分离物对血小板聚合和释放具有更大的抑制作用.
科学领域:
- 生物化学 生物化学
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 血栓激素与血小板糖蛋白Ib (Gp Ib) 相互作用,促进血小板激活.
- 已知氨酸可以抑制血栓素与Gp Ib结合.
- 这项研究调查了氨酸是否可以抑制由血栓激发的血小板激活.
研究的目的:
- 为了确定肝素是否抑制血栓激发的血小板激活.
- 评估血栓蛋白-Gp Ib相互作用在肝素抑制作用中的作用.
- 为了评估肝素分子量对其抑制活性的影响.
主要方法:
- 评估血小板聚合和动员,以应对血栓.
- 使用不同分子量的肝素分离物.
- 测试肝素对血小板的作用,其中Gp Ib或修改的血栓蛋白减少.
主要成果:
- 氨酸显著降低了由血栓激发的血小板聚合和释放.
- 肝素的抑制作用是剂量依赖的,与分子量相关.
- 氨酸没有影响ADP或ombin受体激活的血小板激活.
- 肝素的抑制作用取决于血栓激素-Gp Ib相互作用.
结论:
- 氨酸通过干扰氨酸-Gp Ib相互作用来抑制氨酸诱导的血小板激活.
- 肝素分量的分子量直接影响抑制的程度.
- 这些发现突出了特定的肝素分数在调节血小板活性方面的潜在治疗作用.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...

